We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIY icon
2151
BlackRock MuniYield Michigan Quality Fund
MIY
$360M
$1.06M ﹤0.01%
77,382
+3,104
+4% +$42.2K
DAN icon
2152
Dana Inc
DAN
$3.25B
$1.06M ﹤0.01%
53,193
-1,043
-2% -$18.6K
GUNR icon
2153
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.08B
$1.06M ﹤0.01%
32,132
+9,261
+40% +$300K
HR icon
2154
Healthcare Realty
HR
$6.61B
$1.06M ﹤0.01%
38,668
-5,088
-12% -$143K
STOT icon
2155
State Street DoubleLine Short Duration Total Return Tactical ETF
STOT
$507M
$1.06M ﹤0.01%
21,345
-1,015
-5% -$50K
SGEN
2156
DELISTED
Seagen Inc. Common Stock
SGEN
$1.06M ﹤0.01%
15,313
-7,078
-32% -$496K
MGP
2157
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$1.06M ﹤0.01%
34,576
-718
-2% -$22.8K
JHMM icon
2158
John Hancock Multifactor Mid Cap ETF
JHMM
$6.13B
$1.06M ﹤0.01%
29,016
-169
-0.6% -$6.06K
CUTR
2159
DELISTED
Cutera, Inc.
CUTR
$1.06M ﹤0.01%
50,959
+1,884
+4% +$33.7K
APYX icon
2160
Apyx Medical
APYX
$136M
$1.06M ﹤0.01%
157,288
+25,000
+19% +$136K
EQT icon
2161
EQT Corp
EQT
$33.7B
$1.05M ﹤0.01%
66,734
+22,881
+52% +$439K
SCHG icon
2162
Schwab US Large-Cap Growth ETF
SCHG
$63B
$1.05M ﹤0.01%
101,040
+336
+0.3% +$3.42K
AQN icon
2163
Algonquin Power & Utilities
AQN
$4.43B
$1.05M ﹤0.01%
86,782
+2,170
+3% +$25.4K
HAE icon
2164
Haemonetics
HAE
$3.98B
$1.05M ﹤0.01%
8,688
-1,427
-14% -$140K
WW
2165
DELISTED
WW International
WW
$1.05M ﹤0.01%
54,761
-4,945
-8% -$98K
BMTC
2166
DELISTED
Bryn Mawr Bank Corp
BMTC
$1.04M ﹤0.01%
28,001
-180
-0.6% -$6.74K
GNW icon
2167
Genworth Financial
GNW
$3.71B
$1.04M ﹤0.01%
280,815
+6,042
+2% +$21.4K
OMCL icon
2168
Omnicell
OMCL
$1.69B
$1.04M ﹤0.01%
12,116
-2,449
-17% -$199K
AVP
2169
DELISTED
Avon Products, Inc.
AVP
$1.04M ﹤0.01%
267,948
-264,928
-50% -$883K
AZUL
2170
DELISTED
Azul
AZUL
$1.04M ﹤0.01%
+31,085
New +$902K
MLKN icon
2171
MillerKnoll
MLKN
$1.64B
$1.04M ﹤0.01%
23,245
-340
-1% -$12.9K
RZG icon
2172
Invesco S&P SmallCap 600 Pure Growth ETF
RZG
$138M
$1.03M ﹤0.01%
27,861
+336
+1% +$12.5K
TEX icon
2173
Terex
TEX
$7.74B
$1.03M ﹤0.01%
32,892
+2,249
+7% +$69K
TGNA
2174
DELISTED
TEGNA Inc
TGNA
$1.03M ﹤0.01%
68,189
-1,230
-2% -$18.9K
TCBK icon
2175
TriCo Bancshares
TCBK
$1.83B
$1.03M ﹤0.01%
27,293

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.